Krystal Biotech, Inc. (KRYS)
246.54
-1.34
(-0.54%)
USD |
NASDAQ |
Dec 31, 16:00
246.71
+0.17
(+0.07%)
After-Hours: 20:00
Krystal Biotech Market Cap: 7.149B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DexCom, Inc. | 25.89B |
| Alnylam Pharmaceuticals, Inc. | 52.54B |
| Vanda Pharmaceuticals, Inc. | 520.94M |
| ADMA Biologics, Inc. | 4.341B |
| Aldeyra Therapeutics, Inc. | 311.34M |
Market Cap Related Metrics
| PE Ratio | 36.98 |
| PS Ratio | 19.71 |
| PEG Ratio | 0.1334 |
| Price to Book Value | 6.283 |
| Price to Free Cash Flow | 44.42 |
| Price | 246.54 |
| Earnings Yield | 2.70% |
| PEGY Ratio | 0.1334 |
| Operating PE Ratio | 46.48 |
| Normalized PE Ratio | 36.98 |